오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

coregas pty ltd - carbon dioxide, quantity: 100 % v/v - gas, medicinal - excipient ingredients: - this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. indications held in artg paper records. (old code)

오스트레일리아 - 영어 - APVMA (Australian Pesticides and Veterinary Medicines Authority)

kd plant care pty ltd - fluroxypyr as the methyl heptyl ester; liquid hydrocarbon - emulsifiable concentrate - fluroxypyr as the methyl heptyl ester pyridine-pyridinoxy active 200.0 g/l; liquid hydrocarbon solvent other 580.0 g/l - herbicide - barley | commercial/industrial land | fallow or prior to seeding a crop | forest | grass pasture - established (see label) | luc - acacia genus | acacia leiocalyx (wattle) | amaranth or amaranthus | annual gooseberry | anoda weed | apple-of-peru | balsam pear | bathurst burr | bedstraw | bellvine | bellyache bush | black bindweed | blackberry nightshade | bladder ketmia | blue billygoat weed | blue heliotrope or blue top | blue snakeweed | boggabri weed | bokhara clover | brigalow | broadleaf pepper tree | brown salwood or hickory wattle | caltrop or yellow vine | centro | chinee apple | chinese celtis - seedling | cleavers | cobbler's pegs | cockspur thorn | common sensitive plant | cowpea | cowvine | deadnettle | dock | dwarf amaranth or boggabri weed | flannel weed - sida cordifolia | fumitory | giant or black pigweed | giant sensitive plant | gooseberry | green amaranth | ground or annual ground cherry | hairy wandering jew | honey locust | lablab bean | lantana - lantana camara | lantana spp. | lesser swinecress or bittercress | limebush | madeira vine | marsh or smallflower mallow | melilotus or hexham scent | milkweed | mimosa bus

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - cisatracurium besilate, quantity: 201 mg (equivalent: cisatracurium, qty 150 mg) - injection, solution - excipient ingredients: benzenesulfonic acid; water for injections - indicated for use during surgical and other procedures and in intensive care to relax skeletal muscles, and to facilitate tracheal intubation and mechanical ventilation. it is used as an adjunct to general anaesthesia, or sedation in the intensive care unit

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - cisatracurium besilate, quantity: 6.7 mg (equivalent: cisatracurium, qty 5 mg) - injection, solution - excipient ingredients: water for injections; benzenesulfonic acid - indicated for use during surgical and other procedures and in intensive care to relax skeletal muscles, and to facilitate tracheal intubation and mechanical ventilation. it is used as an adjunct to general anaesthesia, or sedation in the intensive care unit

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - cisatracurium besilate, quantity: 26.8 mg (equivalent: cisatracurium, qty 20 mg) - injection, solution - excipient ingredients: water for injections; benzenesulfonic acid - indicated for use during surgical and other procedures and in intensive care to relax skeletal muscles, and to facilitate tracheal intubation and mechanical ventilation. it is used as an adjunct to general anaesthesia, or sedation in the intensive care unit

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - cisatracurium besilate, quantity: 67 mg (equivalent: cisatracurium, qty 50 mg) - injection, solution - excipient ingredients: benzenesulfonic acid; water for injections - indicated for use during surgical and other procedures and in intensive care to relax skeletal muscles, and to facilitate tracheal intubation and mechanical ventilation. it is used as an adjunct to general anaesthesia, or sedation in the intensive care unit

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - cisatracurium besilate, quantity: 13.4 mg (equivalent: cisatracurium, qty 10 mg) - injection, solution - excipient ingredients: water for injections; benzenesulfonic acid - indicated for use during surgical and other procedures and in intensive care to relax skeletal muscles, and to facilitate tracheal intubation and mechanical ventilation. it is used as an adjunct to general anaesthesia, or sedation in the intensive care unit

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - midazolam, quantity: 15 mg - injection, solution - excipient ingredients: sodium hydroxide; water for injections; sodium chloride; hydrochloric acid - ? iv as an agent for conscious sedation prior to short surgical, diagnostic, therapeutic or endoscopic procedures, such as bronchoscopy, gastroscopy, cystoscopy, coronary angiography and cardiac catheterisation, either alone or in conjunction with a narcotic;,? iv for induction of anaesthesia, preliminary to administration of other anaesthetic agents. with the use of a narcotic premedicant, induction of anaesthesia can be attained with a narrower dose range and in a shorter period of time.,? iv for sedation in intensive care units; intermittent administration or continuous infusion.,? im for preoperative sedation (induction of sleepiness or drowsiness and relief of apprehension) and to impair memory of perioperative events.

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - midazolam, quantity: 5 mg - injection, solution - excipient ingredients: water for injections; hydrochloric acid; sodium hydroxide; sodium chloride - ? iv as an agent for conscious sedation prior to short surgical, diagnostic, therapeutic or endoscopic procedures, such as bronchoscopy, gastroscopy, cystoscopy, coronary angiography and cardiac catheterisation, either alone or in conjunction with a narcotic;,? iv for induction of anaesthesia, preliminary to administration of other anaesthetic agents. with the use of a narcotic premedicant, induction of anaesthesia can be attained with a narrower dose range and in a shorter period of time.,? iv for sedation in intensive care units; intermittent administration or continuous infusion.,? im for preoperative sedation (induction of sleepiness or drowsiness and relief of apprehension) and to impair memory of perioperative events.

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - midazolam, quantity: 5 mg - injection, solution - excipient ingredients: hydrochloric acid; sodium chloride; sodium hydroxide; water for injections - ? iv as an agent for conscious sedation prior to short surgical, diagnostic, therapeutic or endoscopic procedures, such as bronchoscopy, gastroscopy, cystoscopy, coronary angiography and cardiac catheterisation, either alone or in conjunction with a narcotic;,? iv for induction of anaesthesia, preliminary to administration of other anaesthetic agents. with the use of a narcotic premedicant, induction of anaesthesia can be attained with a narrower dose range and in a shorter period of time.,? iv for sedation in intensive care units; intermittent administration or continuous infusion.,? im for preoperative sedation (induction of sleepiness or drowsiness and relief of apprehension) and to impair memory of perioperative events.